» Articles » PMID: 30081878

Frequency of Foot Ulcers in People with Type 2 Diabetes, Presenting to Specialist Diabetes Clinic at a Tertiary Care Hospital, Lahore, Pakistan

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2018 Aug 8
PMID 30081878
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetic foot ulceration is a serious limb-threatening complication of diabetes. It is the common cause of hospital admissions and amputations. The objective of the study was to determine the prevalence of diabetic foot ulcers (DFU) and its association with age, gender, duration of diabetes, peripheral neuropathy (PN), peripheral arterial disease (PAD) and HbA1c.

Methods: A total of 1940 people (≥ 30 years of age) with type 2 diabetes coming to the Sakina Institute of Diabetes and Endocrine Research (specialist diabetes clinic) at Shalamar Hospital, Lahore, Pakistan, were recruited over a period of 1 year from January 2016 to January 2017. The foot ulcers were identified according to the University of Texas classification. PN was assessed by biothesiometer and PAD by ankle-brachial index (< 0.9). Body weight, height, body mass index (BMI), HbA1c and duration of diabetes were recorded.

Results: The prevalence of DFU was 7.02%, of which 4.5% of the ulcers were on the planter and 2.6% on the dorsal surface of the foot; 8.5% of the persons had bilateral foot ulcers and 0.4% subjects had Charcot deformity. There was significant association of foot ulcers with age, duration of diabetes, HbA1c, PN and PAD, whereas no association was observed with gender and BMI. PN and PAD were observed in 26.3 and 6.68% of people with diabetes respectively. Neuropathic ulcers and neuro-ischemic ulcers were identified in 74 and 19% of the study population. Logistic regression analysis revealed significant odds ratio for peripheral neuropathy 23.9 (95% confidence interval (5.41-105.6).

Conclusions: Peripheral neuropathy is the commonest cause of foot ulcers. An optimum control of blood glucose to prevent neuropathy and regular feet examination of every person with diabetes may go a long way in preventing foot ulceration.

Citing Articles

Incidence and predictors of diabetic foot ulcer among patients with diabetes mellitus in a diabetic follow-up clinic in Central Ethiopia: a retrospective follow-up study.

Mekuria Negussie Y, Komicha M, Abebe T BMJ Open. 2024; 14(6):e085281.

PMID: 38908850 PMC: 11328629. DOI: 10.1136/bmjopen-2024-085281.


Diabetes and its associated factors: A Retrospective cohort analysis of a large database at Indus Hospital Health Network.

Amin F, Imran M, Hafeez S, Zehra B Pak J Med Sci. 2024; 40(2ICON Suppl):S10-S14.

PMID: 38328649 PMC: 10844897. DOI: 10.12669/pjms.40.2(ICON).8948.


Epidemiological Insights into Diabetic Foot Amputation and its Correlates: A Provincial Study.

Aalaa M, Vahdani A, Tehrani M, Mehrdad N, Zohdirad M, Sadati M Clin Med Insights Endocrinol Diabetes. 2024; 17:11795514241227618.

PMID: 38298327 PMC: 10826372. DOI: 10.1177/11795514241227618.


Efficacy and safety of unilateral tibial cortex transverse transport on bilateral diabetic foot ulcers: A propensity score matching study.

Qin W, Nie X, Su H, Ding Y, He L, Liu K J Orthop Translat. 2023; 42:137-146.

PMID: 37736148 PMC: 10509564. DOI: 10.1016/j.jot.2023.08.002.


The prevalence of peripheral neuropathy among the patients with diabetes in Pakistan: a systematic review and meta-analysis.

Akhtar S, Hassan F, Saqlain S, Ali A, Hussain S Sci Rep. 2023; 13(1):11744.

PMID: 37474792 PMC: 10359406. DOI: 10.1038/s41598-023-39037-1.


References
1.
Abbott C, Carrington A, ASHE H, Bath S, Every L, Griffiths J . The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002; 19(5):377-84. DOI: 10.1046/j.1464-5491.2002.00698.x. View

2.
Gupta A, Humke S . The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol. 2000; 10(5):379-84. View

3.
Wu S, Driver V, Wrobel J, Armstrong D . Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007; 3(1):65-76. PMC: 1994045. View

4.
Al-Maskari F, El-Sadig M . Prevalence of risk factors for diabetic foot complications. BMC Fam Pract. 2007; 8:59. PMC: 2174471. DOI: 10.1186/1471-2296-8-59. View

5.
Hedetoft C, Rasmussen A, Fabrin J, Kolendorf K . Four-fold increase in foot ulcers in type 2 diabetic subjects without an increase in major amputations by a multidisciplinary setting. Diabetes Res Clin Pract. 2008; 83(3):353-7. DOI: 10.1016/j.diabres.2008.11.025. View